Cardiovascular Risk trials recruiting in Alabama

Fewer than 3 recruiting trials found.

All Cardiovascular Risk trials nationally

Cities in Alabama

Recruiting trials in Alabama

• AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
  NCT07797335 · Phase: Phase 3 · Ages: 45 Years and older · Sex: All (male and female) · Alabama: Birmingham, Fairhope, Montgomery